Matthews International Corp (MATW) · Nov 20, 2026 · Earnings
Beat — Adjusted EPS $0.39 vs ~$0.27 consensus
Matthews International earnings beat Q4 consensus, helped by Memorialization and debt reduction, but engineering weakness and absent FY27 guidance keep the reset unfinished.
Matthews is emerging from a two-year portfolio reshaping: it has sold major businesses, is concentrating on Memorialization and Industrial Technologies, and is still trying to repair its engineering operations while extracting value from its Propelis investment. The prior bar had already been lowered to $158–$162 million of fiscal 2026 adjusted EBITDA amid engineering delays and an ongoing strategic-alternatives review.
The quarter beat the published bar, but the underlying earnings trend is still down. Adjusted EPS of $0.39 exceeded the published consensus of roughly $0.27, while sales of $256.7 million were modestly above the roughly $252.7 million consensus. That is a genuine quarterly beat, but adjusted EPS fell from $0.50 a year earlier and adjusted EBITDA fell to $46.5 million from $51.5 million. The improvement is therefore relative to expectations, not a return to prior-year earnings power.
| Metric | Q4 2026 | Q4 2025 | Consensus |
|---|---|---|---|
| Sales (Financial Highlights) | $256.7M | $318.8M | $252.7M |
| Adjusted EPS (Adjusted net income reconciliation) | $0.39 | $0.50 | $0.27 |
| Adjusted EBITDA (Adjusted EBITDA reconciliation) | $46.5M | $51.5M | |
| FY2026 adjusted EBITDA (Adjusted EBITDA reconciliation) | $161.5M | $187.5M | $158M–$162M guide |
| FY2026 operating cash flow (Cash Flow statement) | $(58.0)M | $(23.6)M |
Memorialization is the clear operating bright spot. Quarterly sales rose to $214.6 million from $209.7 million and adjusted EBITDA increased to $47.0 million from $45.1 million, supported by mausoleum demand, pricing, cost savings, and better cremation-equipment performance. The company says, “Memorialization achieved record annual sales, up 4%, driven in part by The Dodge Company acquisition, while adjusted EBITDA also reached a record level with margin expansion.” 〔0〕
Industrial Technologies remains the main drag. Product Identification sales grew 14%, but engineering weakness and customer delays pushed the segment to a $3.1 million quarterly adjusted EBITDA loss versus $11.0 million of profit last year. The restructuring program is intended to produce $10 million of annual savings, but this quarter shows that the savings have not yet offset the lost engineering volume. The filing states, “Our engineering business continues to face customer delays related to ongoing litigation.” 〔1〕
Debt reduction helps, but cash generation is not yet clean. Total debt fell by $100.4 million year over year, and net debt declined by $94.1 million, helped by divestiture proceeds. The company states, “The December 2025 sale of our warehouse automation business helped reduce debt by $100.4 million year over year.” However, operating cash flow worsened to negative $58.0 million, partly reflecting litigation, restructuring, and transaction-related costs, while leverage remained 3.6 times adjusted EBITDA.
The missing FY2027 outlook limits how far this beat can reset the story. Management is still evaluating strategic alternatives and did not provide full-year fiscal 2027 guidance, citing economic uncertainty, engineering litigation, and unfinished go-forward strategy work. The filing says, “Accordingly, we are not providing full-year fiscal 2027 guidance at this time.” 〔2〕 That makes the earnings beat useful evidence of near-term execution, but not yet a clear signal that the broader turnaround is complete.
Bottom line: Matthews delivered a narrow earnings beat and showed real strength in Memorialization and debt reduction. But the engineering loss, weaker cash flow, and absence of fiscal 2027 guidance leave the broader restructuring story only modestly improved.
Fiscal Q1 2027 earnings report, expected late January
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!